Related Experiment Videos
Nonresponses and treatment failures with conventional empiric regimens in patients with community-acquired pneumonia
1Section of Infectious Disease, Department of Internal Medicine, Northeastern Ohio Universities College of Medicine, Rootstown, OH, USA. tanj@summa-health.org
Abstract:
Although most patients with suspected CAP respond to empiric therapy,a small number of patients do not respond in the expected fashion. Age and underlying comorbid conditions have a strong influence on the course of illness. Less common causes of treatment failures include overwhelming infection, antimicrobial resistance, and misdiagnosis. It is a common practice for empiric antimicrobial treatment of CAP to be initiated without microbiologic studies. Clinicians carefully should observe these patients for unusual or slow responses and should be ready to pursue a more extensive search for the cause of treatment failure.
Insights
Most community-acquired pneumonia (CAP) patients respond to empiric therapy. However, treatment failures can occur due to factors like age, comorbidities, resistant microbes, or misdiagnosis, necessitating careful clinical observation.
Area of Science:
- Infectious Diseases
- Internal Medicine
- Pulmonology
Background:
- Community-acquired pneumonia (CAP) is a common infection often treated empirically.
- A subset of patients does not respond as expected to initial antibiotic treatment.
- Factors influencing treatment outcomes include patient demographics and underlying health conditions.
Purpose of the Study:
- To discuss the reasons for treatment failure in community-acquired pneumonia.
- To highlight the importance of clinical observation in managing non-responsive CAP cases.
- To emphasize the need for further investigation when empiric therapy fails.
Main Methods:
- Review of clinical practices and literature regarding CAP treatment outcomes.
- Analysis of factors contributing to treatment non-response.
- Discussion of diagnostic and therapeutic considerations for refractory cases.
Main Results:
- Patient age and comorbidities significantly impact CAP treatment response.
- Less frequent causes of failure include overwhelming infection, antimicrobial resistance, and diagnostic errors.
- Empiric CAP treatment is often initiated without initial microbiologic data.
Conclusions:
- Close monitoring of CAP patients for atypical responses is crucial.
- Clinicians should be prepared to conduct further investigations for treatment failures.
- Identifying the cause of non-response is key to successful patient management.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia
Acute Pyelonephritis II: Diagnostic Studies and Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...